Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Surg Oncol. 2016 Apr;113(5):473–476. doi: 10.1002/jso.24181

Table 3.

Univariable & multivariable analysis of 148 patients with liver colorectal metastases only

Univariable Analysis Multivariable Analysis
Factor Number 5 year survival P Value Hazard Ration 95% Confidence Intervals P value
Before 2000 61 10% <0.001 2.70 1.28 – 5.69 0.01
After 2000 87 40%
Number of Liver Metastases: >4 57 25% 0.13 0.95 0.48 – 1.99 0.95
           1–4 62 42%
Volume of Liver Metastases: >30% 41 21% 0.007 1.24 0.60 – 2.51 0.43
           <30% 52 44%
Bilobar Liver Metastases: Yes 98 24% 0.01 0.69 0.27 – 1.74 0.43
          No 41 42%
CEA: >65 51 24% 0.27
  <64 49 41%
Sex: Female 77 33% 0.49
  Male 71 23%
HAIP Chemotherapy: Yes 66 34% 0.03 0.96 0.48 – 1.81 0.95
         No 82 22%
Liver Resection: Yes 80 46% <0.001 6.23 2.99 – 12.97 <0.001
       No 66 6%
Resection of Primary: Yes 135 31% <0.001 3.06 1.13 – 8.27 0.03
         No 12 0%
Node positive primary: Yes 107 29% 0.16
         No 23 42%
Site of Primary Tumor: Rectum 38 25% 0.21
         Left Colon 72 34% 0.68 0.25 – 1.81 0.44
         Right Colon 38 18% 0.80 0.37 – 1.70 0.56
Pregnant: Yes 10 30% 0.39
    No 138 28%
Inflammatory bowel disease: Yes 5 20% 0.55
           No 143 28%